UnitedHealth Group Incorporated (NYSE:UNH) Position Reduced by Generate Investment Management Ltd

Generate Investment Management Ltd lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 34.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 43,918 shares of the healthcare conglomerate’s stock after selling 22,820 shares during the quarter. UnitedHealth Group makes up about 1.7% of Generate Investment Management Ltd’s holdings, making the stock its 20th biggest holding. Generate Investment Management Ltd’s holdings in UnitedHealth Group were worth $25,678,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Buckingham Capital Management Inc. grew its position in UnitedHealth Group by 1.4% during the first quarter. Buckingham Capital Management Inc. now owns 25,283 shares of the healthcare conglomerate’s stock valued at $12,508,000 after purchasing an additional 337 shares in the last quarter. Triangle Securities Wealth Management increased its stake in shares of UnitedHealth Group by 1.7% in the first quarter. Triangle Securities Wealth Management now owns 4,177 shares of the healthcare conglomerate’s stock worth $2,066,000 after acquiring an additional 70 shares during the last quarter. Johnson & White Wealth Management LLC boosted its position in UnitedHealth Group by 4.9% during the first quarter. Johnson & White Wealth Management LLC now owns 1,532 shares of the healthcare conglomerate’s stock valued at $758,000 after purchasing an additional 71 shares during the last quarter. BTC Capital Management Inc. acquired a new position in UnitedHealth Group in the 1st quarter worth about $7,827,000. Finally, Cardano Risk Management B.V. grew its stake in shares of UnitedHealth Group by 4.0% in the 1st quarter. Cardano Risk Management B.V. now owns 200,595 shares of the healthcare conglomerate’s stock valued at $99,234,000 after buying an additional 7,626 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.6 %

UnitedHealth Group stock opened at $569.61 on Friday. The stock has a market cap of $525.99 billion, a price-to-earnings ratio of 37.77, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The business has a 50 day moving average price of $584.42 and a two-hundred day moving average price of $533.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.56 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.47%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is 55.70%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Cantor Fitzgerald lifted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday. Argus upped their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.